Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claus Vogelmeier

Showing results (51-60 of 158) with videos related to

Pageof 16
Sort By:
Respiratory Medicine|July 23, 2017
Exacerbations and duration of smoking abstinence are associated with the annual loss of FEV<sub>1</sub> in individuals with PiZZ alpha-1-antitrypsin deficiencySebastian Fähndrich, Nikolas Bernhard, Philipp M Lepper, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 9, 2016
A year in the life of German patients with COPD: the DACCORD observational studyRoland Buhl, Carl-Peter Criée, Peter Kardos, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 30, 2017
Deterioration of quality of life is associated with the exacerbation frequency in individuals with alpha-1-antitrypsin deficiency - analysis from the German RegistryNikolas Bernhard, Philipp M Lepper, Claus Vogelmeier, et al.
The European Respiratory Journal|April 21, 2018
Pharmacological treatment of COPD: the devil is always in the detailDave Singh, Peter J Barnes, Robert Stockley, et al.
Respiratory Research|October 6, 2010
Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropiumClaus Vogelmeier, David Ramos-Barbon, Damon Jack, et al.
European Journal of Immunology|February 9, 2010
The antimicrobial peptide LL-37 modulates the inflammatory and host defense response of human neutrophilsSadek M Alalwani, Johannes Sierigk, Christian Herr, et al.
Disease Markers|November 9, 2005
TNF-alpha, TNF-beta, IL-6, and IL-10 polymorphisms in patients with lung cancerCarola Seifart, Alexandra Plagens, Astrid Dempfle, et al.
Respiratory Medicine|December 6, 2017
Intensive smoking diminishes the differences in quality of life and exacerbation frequency between the alpha-1-antitrypsin deficiency genotypes PiZZ and PiSZNikolas Bernhard, Philipp M Lepper, Claus Vogelmeier, et al.
Respiratory Medicine|June 22, 2013
Alpha1-antitrypsin deficiency - diagnostic testing and disease awareness in Germany and ItalyTimm Greulich, Stefania Ottaviani, Robert Bals, et al.
Respiration; International Review of Thoracic Diseases|October 10, 2009
Acute and chronic effects of smoking on inflammation markers in exhaled breath condensate in current smokersA-Rembert Koczulla, Sarah Noeske, Christian Herr, et al.
Pageof 16

Showing results (51-60 of 158) with videos related to

Sort By:
Pageof 16
Respiratory Medicine|July 23, 2017
Exacerbations and duration of smoking abstinence are associated with the annual loss of FEV<sub>1</sub> in individuals with PiZZ alpha-1-antitrypsin deficiencySebastian Fähndrich, Nikolas Bernhard, Philipp M Lepper, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 9, 2016
A year in the life of German patients with COPD: the DACCORD observational studyRoland Buhl, Carl-Peter Criée, Peter Kardos, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 30, 2017
Deterioration of quality of life is associated with the exacerbation frequency in individuals with alpha-1-antitrypsin deficiency - analysis from the German RegistryNikolas Bernhard, Philipp M Lepper, Claus Vogelmeier, et al.
The European Respiratory Journal|April 21, 2018
Pharmacological treatment of COPD: the devil is always in the detailDave Singh, Peter J Barnes, Robert Stockley, et al.
Respiratory Research|October 6, 2010
Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropiumClaus Vogelmeier, David Ramos-Barbon, Damon Jack, et al.
European Journal of Immunology|February 9, 2010
The antimicrobial peptide LL-37 modulates the inflammatory and host defense response of human neutrophilsSadek M Alalwani, Johannes Sierigk, Christian Herr, et al.
Disease Markers|November 9, 2005
TNF-alpha, TNF-beta, IL-6, and IL-10 polymorphisms in patients with lung cancerCarola Seifart, Alexandra Plagens, Astrid Dempfle, et al.
Respiratory Medicine|December 6, 2017
Intensive smoking diminishes the differences in quality of life and exacerbation frequency between the alpha-1-antitrypsin deficiency genotypes PiZZ and PiSZNikolas Bernhard, Philipp M Lepper, Claus Vogelmeier, et al.
Respiratory Medicine|June 22, 2013
Alpha1-antitrypsin deficiency - diagnostic testing and disease awareness in Germany and ItalyTimm Greulich, Stefania Ottaviani, Robert Bals, et al.
Respiration; International Review of Thoracic Diseases|October 10, 2009
Acute and chronic effects of smoking on inflammation markers in exhaled breath condensate in current smokersA-Rembert Koczulla, Sarah Noeske, Christian Herr, et al.
Pageof 16